BC
EW icon

Bowman & Company’s Edwards Lifesciences EW Stock Holding History

Bowman & Company’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$717K Sell
8,407
-20
-0.2% -$1.64K 0.3% 68
2025
Q3 		$655K Sell
8,427
-13
-0.2% -$1.02K 0.28% 75
2025
Q2 		$660K Sell
8,440
-5,138
-38% -$383K 0.29% 71
2025
Q1 		$984K Buy
13,578
+1,091
+9% +$78.1K 0.48% 62
2024
Q4 		$924K Buy
12,487
+148
+1% +$10.4K 0.48% 63
2024
Q3 		$814K Buy
12,339
+1,412
+13% +$103K 0.43% 67
2024
Q2 		$1.01M Buy
10,927
+993
+10% +$87.9K 0.58% 49
2024
Q1 		$949K Sell
9,934
-322
-3% -$27K 0.57% 56
2023
Q4 		$782K Buy
10,256
+830
+9% +$57.8K 0.54% 56
2023
Q3 		$653K Buy
9,426
+1,753
+23% +$141K 0.52% 56
2023
Q2 		$724K Buy
7,673
+192
+3% +$16.7K 0.55% 51
2023
Q1 		$619K Buy
7,481
+2,936
+65% +$231K 0.45% 52
2022
Q4 		$339K Sell
4,545
-1,620
-26% -$125K 0.26% 68
2022
Q3 		$509K Buy
6,165
+240
+4% +$23.1K 0.46% 44
2022
Q2 		$563K Buy
5,925
+270
+5% +$28K 0.49% 42
2022
Q1 		$666K Buy
5,655
+91
+2% +$10.2K 0.51% 39
2021
Q4 		$722K Buy
+5,564
New +$649K 0.56% 29

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Bowman & Company's EW Position: Q4 2025 in Review

Bowman & Company reduced its Edwards Lifesciences (EW) stake by 0.24% in Q4 2025, selling an estimated $1.64K and leaving 8,407 shares worth $717K. The position accounts for 0.3% of the portfolio, ranked #68.

Bowman & Company first reported a position in EW in Q4 2021 and has held it in 17 quarters since. The position peaked at $1.01M in Q2 2024. 1,314 funds tracked by Wall St. Rank hold EW as of Q4 2025.

  • Bowman & Company held 8,407 shares of Edwards Lifesciences worth $717K as of Q4 2025.
  • Bowman & Company sold 20 Edwards Lifesciences shares in Q4 2025, an estimated $1.64K.
  • Edwards Lifesciences made up 0.3% of Bowman & Company's portfolio in Q4 2025, its #68 holding.
  • Bowman & Company first reported a position in Edwards Lifesciences in Q4 2021 and has held it in 17 quarters since.
  • Bowman & Company's Edwards Lifesciences position peaked at $1.01M in Q2 2024.
  • 1,314 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2025.

Based on Bowman & Company's 13F filing for Q4 2025, filed 23 Jan 2026.